Predictive markers of everolimus efficacy in hormone receptor positive (HR+) metastatic breast cancer (MBC): Final results of the TAMRAD trial translational study.
Isabelle Treilleux
No relevant relationships to disclose
Monica Arnedos
No relevant relationships to disclose
Claire Cropet
No relevant relationships to disclose
Jean-Marc Ferrero
No relevant relationships to disclose
Sophie Abadie Lacourtoisie
No relevant relationships to disclose
Dominique Spaeth
Consultant or Advisory Role - Novartis
Christelle Levy
No relevant relationships to disclose
Eric Legouffe
No relevant relationships to disclose
Eric Pujade-Lauraine
No relevant relationships to disclose
Quing WANG
No relevant relationships to disclose
Thomas Bachelot
Consultant or Advisory Role - Novartis
Research Funding - Novartis